We won't know that until the full results of the lupus trial and smoking cessation are announced, which will surely happen prior to needing to raise more capital. One is targeted for early licensing and the other is 'speed to market' approach, which I assume is meaning the same thing, so a lot hinges on a deal being struck. There is also the chance that the company will recover the money from the court case in the near future.
Article from the life scientist:
http://lifescientist.com.au/content...ll-tolerated-in-asthma-trial-invion-157378962
Thoughts?, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.63M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $869 | 434.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 18551457 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 8526961 | 48 |
View Market Depth
| Last trade - 11.10am 12/11/2024 (20 minute delay) ? |
| IVX (ASX) Chart |